AgingResearch.News
Nature Medicine

Performance and safety of a multi-cancer early detection test: the PATHFINDER 2 study

By Nima Nabavizadeh, Charles McDonnell, Dax Kurbegov, Show 16 more authorsKarthik V. Giridhar
Figure 1 from Nature Medicine
Open the figure at full size
Figure 1. Nabavizadeh et al.
Non-randomised trial in 35,878 peopleBiomarkers

Registered NCT05155605, declared ties to: GRAIL, Exact Sciences, Roche Diagnostics and 56 more

Paper

The paper

Nima Nabavizadeh, Charles McDonnell, Dax Kurbegov, Show 16 more authorsKarthik V. Giridhar

Oregon Health & Science University; Mayo Clinic

Nature Medicine, 22 Sep 2026

doi.org/10.1038/s41591-026-04618-wPubMed 42773207

More on Cancer